Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial. Conference

Al-Batran, Salah-Eddin, Lorenzen, Sylvie, Riera, Jorge et al. (2024). Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial. . JOURNAL OF CLINICAL ONCOLOGY, 42(17_SUPPL), LBA4001-LBA4001. 10.1200/JCO.2024.42.17_suppl.LBA4001

Open Access International Collaboration

cited authors

  • Al-Batran, Salah-Eddin; Lorenzen, Sylvie; Riera, Jorge; Caca, Karel; Mueller, Christian; Stange, Daniel E; Zander, Thomas; Bolling, Claus; Homann, Nils; Gaedcke, Jochen; Thuss-Patience, Peter C; Michl, Patrick; Blau, Wolfgang; Wille, Kai; Koch, Christine; Pauligk, Claudia; Mueller, Daniel Wilhelm; Bankstahl, Ulli Simone; Moenig, Stefan Paul; Goetze, Thorsten

sustainable development goals

authors

publication date

  • June 10, 2024

published in

keywords

  • 1
  • 14
  • 2
  • 261-492-3532-2370-7650-2700
  • 261-492-574
  • 261-566-148
  • 283-2494-7461
  • 291
  • 3
  • 3282-270-434-6184
  • 4
  • 6
  • 613-4678-146-2641
  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • LBA4001

end page

  • LBA4001

volume

  • 42

issue

  • 17_SUPPL